Yazmín Odia
Impact in
- Genetics top 2%
- Glioma Diagnosis and Treatment
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
Papers in
- Genetics 50
- Glioma Diagnosis and Treatment 50
-
- Brain Metastases and Treatment 26
- Co-authors
- Brent A. Orr (4 shared papers)Charles G. Eberhart (4 shared papers)Rupesh Kotecha (34 shared papers)Teri Kreisl (6 shared papers)Minesh P. Mehta (37 shared papers)Robert A. Anders (1 shared paper)Deepali Jain (1 shared paper)Haibo Bai (1 shared paper)
- Journals
- Journal of Clinical Oncology (17 papers)Neuro-Oncology (15 papers)Journal of Neuro-Oncology (8 papers)Neuro-Oncology Advances (7 papers)Neurology (4 papers)
- Partner nations
- United StatesIndiaUnited Kingdom
In The Last Decade
Yazmín Odia
81 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 94
- Genetics 569
- Cancer Research 195
- Neurology 174
- Endocrinology, Diabetes and Metabolism 163
- Family Practice 18
Countries citing papers authored by Yazmín Odia
This map shows the geographic impact of Yazmín Odia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yazmín Odia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yazmín Odia more than expected).
Fields of papers citing papers by Yazmín Odia
This network shows the impact of papers produced by Yazmín Odia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yazmín Odia. The network helps show where Yazmín Odia may publish in the future.
Co-authors
The 25 scholars most cited alongside Yazmín Odia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 135 | |
| 2 | 2011 | 90 | |
| 3 | 2012 | 67 | |
| 4 | 2019 | 66 | |
| 5 | 2017 | 66 | |
| 6 | 2019 | 60 | |
| 7 | 2013 | 59 | |
| 8 | 2023 | 52 | |
| 9 | 2019 | 51 | |
| 10 | 2016 | 48 | |
| 11 | 2010 | 38 | |
| 12 | 2015 | 36 | |
| 13 | 2017 | 35 | |
| 14 | 2015 | 35 | |
| 15 | 2019 | 30 | |
| 16 | 2021 | 25 | |
| 17 | 2020 | 24 | |
| 18 | 2016 | 24 | |
| 19 | 2023 | 22 | |
| 20 | 2013 | 21 |
About Yazmín Odia
Yazmín Odia is a scholar working on Genetics, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Cancer Research, having authored 89 papers that have together received 1.2k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (50 papers), Brain Metastases and Treatment (26 papers), Cancer, Hypoxia, and Metabolism (11 papers), Lung Cancer Research Studies (9 papers), Meningioma and schwannoma management (8 papers), Cancer Treatment and Pharmacology (5 papers), Neuroblastoma Research and Treatments (5 papers) and Nanoplatforms for cancer theranostics (4 papers). The work is most often cited by research in Genetics (569 citations), Cancer Research (195 citations), Neurology (174 citations), Endocrinology, Diabetes and Metabolism (163 citations) and Family Practice (18 citations). Yazmín Odia has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Brent A. Orr, Charles G. Eberhart, Rupesh Kotecha, Teri Kreisl, Minesh P. Mehta, Robert A. Anders, Deepali Jain, Haibo Bai, Manmeet S. Ahluwalia and Howard A. Fine. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, Journal of Neuro-Oncology, Neuro-Oncology Advances and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.